New Directions and Practice-Impacting Recommendations in Plaque Psoriasis
Faculty presenters: Linda Stein Gold, MD (Meeting Chair and Publication Editor); Eingun James Song, MD, FAAP; Kimberly Gutowsy Baker, FNP-C; Mona Shahriari, MD; TJ Chao, MPAS, PA-C; Jennifer Soung, MD; Saakshi Khattri, MD; Adelaide A. Hebert, MD; and Andrew F. Alexis, MD, MPH.
This HCPLive supplement comprises 6 articles that review current approaches in psoriasis care, including mainstay and novel treatment strategies and important safety considerations. The unique impact of psoriasis among populations of pediatric patients and individuals with skin of color is also explored.
New Topical Agents for Treatment of Plaque Psoriasis
February 29th 2024This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Novel Biologics in Psoriasis—Safety Considerations
February 29th 2024This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Psoriasis to Psoriatic Arthritis Progression and Radiographic Findings
February 29th 2024This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Psoriasis in Patients With Skin of Color
February 29th 2024This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
